All Stories

  1. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets

    Article • Drug Design Development and Therapy, May 2019, Dove Medical Press

    Professor Jae-Gook Shin

  2. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects

    Article • Drug Design Development and Therapy, April 2019, Dove Medical Press

    Professor Jae-Gook Shin, Minkyung Oh

  3. Inhibition of Cytochrome P450 Activities by Sophora flavescens Extract and Its Prenylated Flavonoids in Human Liver Microsomes

    Article • Evidence-based Complementary and Alternative Medicine, March 2019, Hindawi Publishing Corporation

    Professor Jae-Gook Shin, shin yumi

  4. Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects

    Article • BioMed Research International, January 2019, Hindawi Publishing Corporation

    Professor Jae-Gook Shin

  5. Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake TransportersIn Vitro

    Article • Antimicrobial Agents and Chemotherapy, July 2018, ASM Journals

    Professor Jae-Gook Shin

  6. Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin-Containing Monooxygenase 3 Maturational Changes Over Time

    Article • The Journal of Clinical Pharmacology, June 2018, Wiley

    Professor Jae-Gook Shin

  7. Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects

    Article • Clinical Pharmacology in Drug Development, June 2018, Wiley

    Professor Jae-Gook Shin

  8. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects

    Article • Drug Design Development and Therapy, May 2018, Dove Medical Press

    Professor Jae-Gook Shin

  9. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers

    Article • Drug Design Development and Therapy, December 2017, Dove Medical Press

    Professor Jae-Gook Shin

  10. Evaluation of para-Aminosalicylic Acid as a Substrate of Multiple Solute Carrier Uptake Transporters and Possible Drug Interactions with Nonsteroidal Anti-inflammatory Drugs In Vitro

    Article • Antimicrobial Agents and Chemotherapy, February 2017, ASM Journals

    Professor Jae-Gook Shin

  11. Functional characterization and genetic effects on ethambutol uptake by organic cation transporter 2 (OCT2)

    Article • Drug Metabolism and Pharmacokinetics, January 2017, Elsevier

    Professor Jae-Gook Shin

  12. Allopurinol-induced severe cutaneous adverse reactions: A report of three cases with the HLA-B*58:01 allele who underwent lymphocyte activation test

    Article • Translational and Clinical Pharmacology, January 2017, Korean Society for Clinical Pharmacology and Therapeutics (KAMJE)

    Professor Jae-Gook Shin

  13. The Effect of Age on the Pharmacokinetics of Udenafil in Healthy Subjects

    Article • The Journal of Clinical Pharmacology, October 2016, Wiley

    Professor Jae-Gook Shin

  14. Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Professor Jae-Gook Shin

  15. Population pharmacokinetics of levofloxacin in Korean patients

    Article • Journal of Chemotherapy, July 2016, Maney Publishing

    Professor Jae-Gook Shin

  16. Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Professor Jae-Gook Shin

  17. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation toCYP2C19andCYP3A5genotypes

    Article • British Journal of Clinical Pharmacology, December 2015, Wiley

    Professor Jae-Gook Shin

  18. Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects

    Article • The Journal of Clinical Pharmacology, December 2015, Wiley

    Professor Jae-Gook Shin

  19. The effect ofGinkgo bilobaextracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects

    Article • British Journal of Clinical Pharmacology, April 2014, Wiley

    Professor Jae-Gook Shin

  20. Effect of renal impairment and haemodialysis on the pharmacokinetics of gemigliptin (LC15-0444)

    Article • Diabetes Obesity and Metabolism, April 2014, Wiley

    Professor Jae-Gook Shin

  21. The Pharmacogenomics of Cytochrome P450s: From Molecular to Clinical Application

    Article • January 2014, Springer Science + Business Media

    Professor Jae-Gook Shin

  22. The effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administration

    Article • The Journal of Clinical Pharmacology, November 2013, Wiley

    Professor Jae-Gook Shin

  23. The Tyrosine Kinase Inhibitor Nilotinib Selectively Inhibits CYP2C8 Activities in Human Liver Microsomes

    Article • Drug Metabolism and Pharmacokinetics, January 2013, Japanese Society for the Study of Xenobiotics

    Professor Jae-Gook Shin

  24. Effect of CYP2C19 Genetic Polymorphism on Pharmacokinetics and Pharmacodynamics and Pharmacodynamics of a New Proton Pump Inhibitor, Ilaprazole

    Article • The Journal of Clinical Pharmacology, July 2012, Wiley

    Professor Jae-Gook Shin

  25. Enantioselective carbonyl reduction of eperisone in human liver microsomes

    Article • Xenobiotica, May 2011, Taylor & Francis

    Professor Jae-Gook Shin

  26. Research Highlights

    Article • Personalized Medicine, January 2009, Future Medicine

    Professor Jae-Gook Shin

  27. Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol

    Article • British Journal of Clinical Pharmacology, July 2008, Wiley

    Professor Jae-Gook Shin

  28. Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations

    Article • Clinica Chimica Acta, February 2008, Elsevier

    Professor Jae-Gook Shin

  29. Severe Leukopenia after Intravenous Cyclophosphamide Pulse Therapy in a Patient Having Cytochrome P450 2A6*1B

    Article • The Journal of the Korean Rheumatism Association, January 2007, The Korean Rheumatism Association (KAMJE)

    Professor Jae-Gook Shin

  30. Sequence-based CYP2D6 Genotyping in the Korean Population

    Article • Therapeutic Drug Monitoring, June 2006, Wolters Kluwer Health

    Professor Jae-Gook Shin

  31. Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans

    Article • Pharmacogenetics, March 2002, Wolters Kluwer Health

    Professor Jae-Gook Shin

  32. Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

    Article • Clinical Pharmacokinetics, January 2002, Springer Science + Business Media

    Professor Jae-Gook Shin

  33. Drug Interaction on Metabolism : Induction of Metabolism

    Article • Journal of the Korean Medical Association, January 1997, Korean Medical Association (KAMJE)

    Professor Jae-Gook Shin

  34. Kinetics of isoniazid transfer into cerebrospinal fluid in patients with tuberculous meningitis

    Article • Journal of Korean Medical Science, January 1990, Korean Academy of Medical Sciences (KAMJE)

    Professor Jae-Gook Shin

  35. Comparative Study of Captopril Tablets on the Bioavailability and the Time Course of Plasma Angiotensin-Converting Enzyme Inhibition

    Article • January 1990, The Korean Society of Cardiology (KAMJE)

    Professor Jae-Gook Shin